Cargando…

Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance

BACKGROUND: Organoids or spheroids have emerged as a physiologically relevant in vitro preclinical model to study patient-specific diseases. A recent study used spheroids of MCF10 cells to model breast cancer progression and identified targetable alterations more similar to those in vivo. Thus, it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingwei, Fang, Kun, Choppavarapu, Lavanya, Yang, Ke, Yang, Yini, Wang, Junbai, Cao, Ruifeng, Jatoi, Ismail, Jin, Victor X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447690/
https://www.ncbi.nlm.nih.gov/pubmed/34535185
http://dx.doi.org/10.1186/s13148-021-01167-6
_version_ 1784569070929051648
author Li, Jingwei
Fang, Kun
Choppavarapu, Lavanya
Yang, Ke
Yang, Yini
Wang, Junbai
Cao, Ruifeng
Jatoi, Ismail
Jin, Victor X.
author_facet Li, Jingwei
Fang, Kun
Choppavarapu, Lavanya
Yang, Ke
Yang, Yini
Wang, Junbai
Cao, Ruifeng
Jatoi, Ismail
Jin, Victor X.
author_sort Li, Jingwei
collection PubMed
description BACKGROUND: Organoids or spheroids have emerged as a physiologically relevant in vitro preclinical model to study patient-specific diseases. A recent study used spheroids of MCF10 cells to model breast cancer progression and identified targetable alterations more similar to those in vivo. Thus, it is practical and essential to explore and characterize the spheroids of the commonly used human breast cancer (BC) cells. METHODS: In this study, we conducted Hi-C analyses in three-dimensional (3D) spheroids of MCF10A, MCF7 and MCF7TR cells and compared TADs and looping genes with those in 2D monolayers. Furthermore, we performed in silico functional analysis on 3D-growth-specific looping genes and to compare patient outcomes with or without endocrinal therapy. Finally, we performed 3C/RT-qPCR validations in 3D spheroids and 3D-FISH confirmations in organoids of breast cancer patient tissues. RESULTS: We found that chromatin structures have experienced drastic changes during the 3D culture growth of BC cells although there is not much change in the quantity of chromatin domains. We also observed that the strengths of looping genes were statistically different between 2D monolayers and 3D spheroids. We further identified novel 3D growth-specific looping genes within Hippo relevant pathways, of which two genes showed potential prognostic values in measuring the outcome of the endocrine treatment. We finally confirmed a few selected genes in Hippo relevant pathways with enhanced looping in organoids of breast cancer patient tissues. CONCLUSIONS: Hence, our work has provided significant insights into our understanding of 3D-growth-specific chromatin architecture in tamoxifen-resistant breast cancer. Our analyses suggest that the strengthened looping-mediated Hippo relevant pathways may contribute to endocrine therapy resistance in breast cancer patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01167-6.
format Online
Article
Text
id pubmed-8447690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84476902021-09-20 Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance Li, Jingwei Fang, Kun Choppavarapu, Lavanya Yang, Ke Yang, Yini Wang, Junbai Cao, Ruifeng Jatoi, Ismail Jin, Victor X. Clin Epigenetics Research BACKGROUND: Organoids or spheroids have emerged as a physiologically relevant in vitro preclinical model to study patient-specific diseases. A recent study used spheroids of MCF10 cells to model breast cancer progression and identified targetable alterations more similar to those in vivo. Thus, it is practical and essential to explore and characterize the spheroids of the commonly used human breast cancer (BC) cells. METHODS: In this study, we conducted Hi-C analyses in three-dimensional (3D) spheroids of MCF10A, MCF7 and MCF7TR cells and compared TADs and looping genes with those in 2D monolayers. Furthermore, we performed in silico functional analysis on 3D-growth-specific looping genes and to compare patient outcomes with or without endocrinal therapy. Finally, we performed 3C/RT-qPCR validations in 3D spheroids and 3D-FISH confirmations in organoids of breast cancer patient tissues. RESULTS: We found that chromatin structures have experienced drastic changes during the 3D culture growth of BC cells although there is not much change in the quantity of chromatin domains. We also observed that the strengths of looping genes were statistically different between 2D monolayers and 3D spheroids. We further identified novel 3D growth-specific looping genes within Hippo relevant pathways, of which two genes showed potential prognostic values in measuring the outcome of the endocrine treatment. We finally confirmed a few selected genes in Hippo relevant pathways with enhanced looping in organoids of breast cancer patient tissues. CONCLUSIONS: Hence, our work has provided significant insights into our understanding of 3D-growth-specific chromatin architecture in tamoxifen-resistant breast cancer. Our analyses suggest that the strengthened looping-mediated Hippo relevant pathways may contribute to endocrine therapy resistance in breast cancer patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01167-6. BioMed Central 2021-09-17 /pmc/articles/PMC8447690/ /pubmed/34535185 http://dx.doi.org/10.1186/s13148-021-01167-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Jingwei
Fang, Kun
Choppavarapu, Lavanya
Yang, Ke
Yang, Yini
Wang, Junbai
Cao, Ruifeng
Jatoi, Ismail
Jin, Victor X.
Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title_full Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title_fullStr Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title_full_unstemmed Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title_short Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
title_sort hi-c profiling of cancer spheroids identifies 3d-growth-specific chromatin interactions in breast cancer endocrine resistance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447690/
https://www.ncbi.nlm.nih.gov/pubmed/34535185
http://dx.doi.org/10.1186/s13148-021-01167-6
work_keys_str_mv AT lijingwei hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT fangkun hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT choppavarapulavanya hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT yangke hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT yangyini hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT wangjunbai hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT caoruifeng hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT jatoiismail hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance
AT jinvictorx hicprofilingofcancerspheroidsidentifies3dgrowthspecificchromatininteractionsinbreastcancerendocrineresistance